» Articles » PMID: 34609597

Changing Trends in Rheumatoid Arthritis Mortality in Mexico, from 1998 to 2017

Overview
Journal Rheumatol Int
Specialty Rheumatology
Date 2021 Oct 5
PMID 34609597
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

The aim was to analyze the distribution and trends of deaths reported for rheumatoid arthritis (RA) in Mexico in 1998-2017. We carried out a cross-sectional study. Data were obtained from Dynamic Cubes, General Direction of Health Information, on deaths related to RA in Mexico. Seropositive RA was diagnosed using the International Classification of Diseases version 10. Variables were categorized by diagnosis, age, and gender. Time trends of age-standardized mortality rates (ASMRs) were analyzed for RA, and the annual percent change (APC) was estimated using Joinpoint trend analysis. We found 714 deaths mentioned as RA and 9,749,956 non-RA deaths between 1998 and 2017. Overall RA mortality decreased from 0.14 in 2004 to 0.04 per 100 000 in 2017 (APC: - 10.3%; 95% CI - 16.5%, - 3.3%), while the non-RA ASMR remained stable. In females, there was an initial increase of 27.3% per year through 1998-2004 and a reduction of - 11.7% per year subsequently, while in males, the APC remained stable between 1998 and 2017. The trend for RA mortality resulted in a cumulative change in the ratio of RA ASMR to non-RA ASMR of - 20.6% in females and + 3.2% in males. Although mortality attributable to RA increased from 1998 to 2004 in Mexico, it began to improve after 2004, particularly in females. Prospective, population-based data could help to identify risk factors that could be altered to improve outcomes.

Citing Articles

Trends in mortality in patients with systemic autoimmune rheumatic diseases (SARD) during the COVID-19 pandemic in Mexico.

Munguia-Realpozo P, Mendoza-Pinto C, Etchegaray-Morales I, Solis-Poblano J, Ayon-Aguilar J, Ramirez-Lara E Rheumatol Int. 2023; 43(9):1611-1619.

PMID: 37349634 PMC: 11162978. DOI: 10.1007/s00296-023-05371-w.

References
1.
Avina-Zubieta J, Thomas J, Sadatsafavi M, Lehman A, Lacaille D . Risk of incident cardiovascular events in patients with rheumatoid arthritis: a meta-analysis of observational studies. Ann Rheum Dis. 2012; 71(9):1524-9. DOI: 10.1136/annrheumdis-2011-200726. View

2.
Sokka T, Abelson B, Pincus T . Mortality in rheumatoid arthritis: 2008 update. Clin Exp Rheumatol. 2008; 26(5 Suppl 51):S35-61. View

3.
Salliot C, van der Heijde D . Long-term safety of methotrexate monotherapy in patients with rheumatoid arthritis: a systematic literature research. Ann Rheum Dis. 2008; 68(7):1100-4. PMC: 2689525. DOI: 10.1136/ard.2008.093690. View

4.
Stoffer M, Schoels M, Smolen J, Aletaha D, Breedveld F, Burmester G . Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update. Ann Rheum Dis. 2015; 75(1):16-22. PMC: 4717391. DOI: 10.1136/annrheumdis-2015-207526. View

5.
Sokka T, Mottonen T, Hannonen P . Mortality in early "sawtooth" treated rheumatoid arthritis patients during the first 8-14 years. Scand J Rheumatol. 1999; 28(5):282-7. DOI: 10.1080/03009749950155463. View